Pharmacokinetics of a novel extended half-life glyco PEGylated factor IX, nonacog beta pegol (N9- GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials. - Tiede, A.; Abdul-Karim, F.; Carcao, M.; Persson, P.; Clausen, W. H. O.; Kearney, S.; Matsushita, T.; Negrier, C.; Oldenburg, J.; Santagostino, E.; Young, G. (Haemophilia, 2017)